STOCK TITAN

Bullfrog AI Holdings Inc - BFRG STOCK NEWS

Welcome to our dedicated news page for Bullfrog AI Holdings (Ticker: BFRG), a resource for investors and traders seeking the latest updates and insights on Bullfrog AI Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bullfrog AI Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bullfrog AI Holdings's position in the market.

Rhea-AI Summary
BullFrog AI Holdings, Inc. announces a fireside chat with CEO Vin Singh and Dr. Daniel R. Weinberger to discuss groundbreaking collaboration with LIBD on psychiatric research using AI and machine learning. The partnership aims to provide new insights into brain disorders and potential treatments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.15%
Tags
AI
-
Rhea-AI Summary
WallachBeth Capital LLC announced that BullFrog AI Holdings, Inc. has completed an underwritten public offering, raising approximately $5.7 million. The company offered 1,507,139 shares of common stock at a public offering price of $3.782 per share. Additionally, the underwriters have a 45-day option to purchase an additional 226,071 shares to cover over-allotments. The offering was managed by WallachBeth Capital, LLC.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.64%
Tags
offering AI
-
Rhea-AI Summary
BullFrog AI Holdings, Inc. (NASDAQ:BFRG) has closed an underwritten public offering, raising approximately $5,700,000 in gross proceeds. The company intends to use the net proceeds for working capital and general corporate purposes. WallachBeth Capital, LLC acted as the sole book-running manager for the offering. The offering was made in accordance with a registration statement on Form S-1 (File No. 333-276740) filed with the SEC and became effective on January 31, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.64%
Tags
offering AI
Rhea-AI Summary
WallachBeth Capital LLC announced that BullFrog AI Holdings, Inc. priced an underwritten public offering of 1,507,139 shares of common stock and accompanying warrants, with gross proceeds of approximately $5,700,000. The offering is expected to close on February 5, 2024, subject to customary closing conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.34%
Tags
offering AI
-
Rhea-AI Summary
BullFrog AI Holdings, Inc. announced the pricing of an underwritten public offering of an aggregate of 1,507,139 shares of common stock and accompanying warrants to purchase 1,507,139 shares of common stock at a public offering price of $3.782 per share, resulting in gross proceeds of approximately $5,700,000. The company also granted the underwriters a 45-day option to purchase an additional 226,071 shares of common stock and/or warrants to cover over-allotments. The net proceeds from the offering will be used for working capital and other general corporate purposes. The offering is expected to close on February 5, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.34%
Tags
offering AI
-
Rhea-AI Summary
BullFrog AI Holdings, Inc. announces the appointment of two distinguished scientific advisors to its advisory board, Dr. Gwenn S. Smith and Dr. Jeremiah Wala. Dr. Smith brings expertise in brain imaging and neuropsychiatry, while Dr. Wala adds clinical insight and computational expertise to the company's scientific advisory board. Both advisors are expected to contribute to the company's mission of developing breakthrough therapies and improving patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.18%
Tags
management AI
Rhea-AI Summary
BullFrog AI Holdings, Inc. announced early results from its collaboration with the Lieber Institute for Brain Development that could revolutionize the understanding and treatment of psychiatric disorders. The collaboration has successfully stratified brain expression data, offering unprecedented insights into psychiatric conditions. The proprietary data from LIBD included gene expression data from over 2,800 brain samples encompassing schizophrenia, bipolar disorder, major depressive disorder, and non-psychiatric control brains. Utilizing graph analytics, BullFrog AI and LIBD have, for the first time, clustered subjects based solely on their biological data, independent of their behavioral diagnoses. This innovative approach has yielded promising insights, highlighting distinct differences and similarities in biological pathways across various brain disorders. The market opportunity for new treatments in psychiatric disorders is vast and underserved, presenting a potential paradigm shift in treatment approaches.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.83%
Tags
AI
-
Rhea-AI Summary
BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) has announced that the Australian Patent Office has issued Patent No. 2019216757 protecting the Company’s novel prodrugs derived from mebendazole and their use in treating cancers and other diseases. This patent further strengthens the intellectual property protection of BF-223 and related compounds, including positive results from a preclinical study demonstrating that BF-223 has anticancer activity in an animal model for glioblastoma. The patented compounds exhibit improved solubility and oral bioavailability relative to the parent drug, addressing a key difficulty associated with the potential use of mebendazole for oncology indications. The company is looking forward to working with strategic partners to monetize this promising asset for the treatment of glioblastoma and other oncology indications.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.13%
Tags
AI
-
Rhea-AI Summary
BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) announces CEO's participation in Webull LIVE! Healthcare Webinar
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.39%
Tags
conferences AI
Rhea-AI Summary
BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) has had an extraordinary year, marked by progress, innovation, and value-adding events. The company successfully completed an $8.4 million IPO listing on Nasdaq and secured an exclusive partnership with Lieber Institute for Brain Development. BullFrog AI has also made significant strides in drug development, including identifying drug targets for colorectal cancer and initiating pre-clinical studies for liver disease and obesity drug candidates. The company has strengthened its intellectual property, licensed improvements to its AI algorithms, and recorded its first earned revenue in the third quarter. BullFrog AI's CEO, Vin Singh, is optimistic about the future, emphasizing the company's focus on securing business and driving revenue through external contracts and partnerships.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.19%
Tags
AI
Bullfrog AI Holdings Inc

Nasdaq:BFRG

BFRG Rankings

BFRG Stock Data

30.27M
2.32M
46.34%
0.79%
6.51%
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Professional, Scientific, and Technical Services
Link
United States
Gaithersburg